MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
NVIDIA
NVDA
Tesla
TSLA
US Stock MarketDetailed Quotes
AMLX Amylyx Pharmaceuticals
- 3.600
- +0.100+2.86%
Close Jan 17 16:00 ET
308.48MMarket Cap-0.94P/E (TTM)
3.665High3.425Low886.15KVolume3.560Open3.500Pre Close3.15MTurnover1.62%Turnover Ratio5.14P/E (Static)85.69MShares19.94952wk High1.57P/B196.88MFloat Cap1.57552wk Low--Dividend TTM54.69MShs Float41.930Historical High--Div YieldTTM6.86%Amplitude1.575Historical Low3.550Avg Price1Lot Size
About Amylyx Pharmaceuticals Company
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.
Company Profile
SymbolAMLX
Company NameAmylyx Pharmaceuticals
Listing DateJan 7, 2022
Issue Price19.00
Founded2013
MarketNASDAQ
Employees384
Fiscal Year Ends12-31
Address43 Thorndike Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-682-0917
Websitehttp://www.amylyx.com
Company Executives
- Name
- Position
- Salary
- Justin Klee
- Co-Chief Executive Officer and Director
- 7.42M
- Joshua Cohen
- Co-Chief Executive Officer and Director
- 7.42M
- Gina M. Mazzariello
- Chief Legal Officer and General Counsel
- 3.01M
- Dr. Camille L. Bedrosian,M.D.
- Chief Medical Officer
- 2.37M
- James M. Frates
- Chief Financial Officer and Principal Accounting Officer
- 3.51M
- Dr. George Mclean Milne, Jr,PhD
- Chairman of the Board
- 385.07K
- Dr. Bernhardt G. Zeiher, F.A.C.P.,F.C.C.P.,M.D.
- Director
- --
- Karen Firestone
- Independent Director
- 681.15K
- Daphne E. Quimi
- Independent Director
- 348.59K
- Paul Fonteyne, M.S.
- Independent Director
- 342.12K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.